Miniatura

Fitxers

654289.pdf (993.16 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2014-02-11

Tots els drets reservats

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/125927

Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1002/ana.24117

Resum

Objective: To report the clinical, radiological, and immunological association of demyelinating disorders with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Methods: Clinical and radiological analysis was done of a cohort of 691 patients with anti-NMDAR encephalitis. Determination of antibodies to NMDAR, aquaporin-4 (AQP4), and myelin oligodendrocyte glycoprotein (MOG) was performed using brain immunohistochemistry and cell-based assays. Results: Twenty-three of 691 patients with anti-NMDAR encephalitis had prominent magnetic resonance imaging (MRI) and/or clinical features of demyelination. Group 1 included 12 patients in whom anti-NMDAR encephalitis was preceded or followed by independent episodes of neuromyelitis optica (NMO) spectrum disorder (5 cases, 4 anti-AQP4 positive) or brainstem or multifocal demyelinating syndromes (7 cases, all anti-MOG positive). Group 2 included 11 patients in whom anti-NMDAR encephalitis occurred simultaneously with MRI and symptoms compatible with demyelination (5 AQ4 positive, 2 MOG positive). Group 3 (136 controls) included 50 randomly selected patients with typical anti-NMDAR encephalitis, 56 with NMO, and 30 with multiple sclerosis; NMDAR antibodies were detected only in the 50 anti-NMDAR patients, MOG antibodies in 3 of 50 anti-NMDAR and 1 of 56 NMO patients, and AQP4 antibodies in 48 of 56 NMO and 1 of 50 anti-NMDAR patients (p < 0.0001 for all comparisons with Groups 1 and 2). Most patients improved with immunotherapy, but compared with anti-NMDAR encephalitis the demyelinating episodes required more intensive therapy and resulted in more residual deficits. Only 1 of 23 NMDAR patients with signs of demyelination had ovarian teratoma compared with 18 of 50 anti-NMDAR controls (p = 0.011). Interpretation: Patients with anti-NMDAR encephalitis may develop concurrent or separate episodes of demyelinating disorders, and conversely patients with NMO or demyelinating disorders with atypical symptoms (eg, dyskinesias, psychosis) may have anti-NMDAR encephalitis.

Matèries

Encefalitis, Receptors cel·lulars

Matèries (anglès)

Encephalitis, Cell receptors

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Citació

TITULAER, Maarten j., HÖFTBERGER, Romana, IIZUKA, Takahiro, LEYPOLDT, Frank, MCCRACKEN, Lindsey, CELLUCCI, Tania, BENSON, Leslie a., SHU, Huidy, IRIOKA, Takashi, HIRANO, Makito, SINGH, Gagandeep, COBO CALVO, Álvaro, KAIDA, Kenichi, MORALES, Pamela s., WIRTZ, Paul w., YAMAMOTO, Tomotaka, REINDL, Markus, ROSENFELD, Myrna r., GRAUS RIBAS, Francesc, SAIZ HINAREJOS, Albert, DALMAU OBRADOR, Josep. Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis. _Annals of Neurology_. 2014. Vol. 75, núm. 3, pàgs. 411-428. [consulta: 14 de gener de 2026]. ISSN: 0364-5134. [Disponible a: https://hdl.handle.net/2445/125927]

Exportar metadades

JSON - METS

Compartir registre